Pharsight Monthly Summary
April, 2026
Recent happenings in patent protected drugs.
spacer_11
At a Glance
79
drug patents lapsed
Photos
68
new drug patents introduced
Reviews
What's New on Pharsight?

Patent Challenge Updates

Discover for which innovator drugs Paragraph IV certifications have been filed, signaling opportunities to launch generics before patent expiry. Find this section right under Generic Launch on any drug page to stay ahead of the market and identify actionable opportunities.

Recent & Tentative Approvals

Track the latest innovator and generic drug approvals along with tentative approvals and submission timelines to identify drugs moving closer to market entry. This helps uncover pipeline momentum, anticipate upcoming launches, and better understand how a company’s portfolio is evolving. Simply search for any company on Pharsight and find this in the Recent Approvals & Tentative Approvals section of the company page.

spacer_11
spacer_11
spacer_11

High Competition Drugs Alert
See which drugs have the most crowded generic market and intense competition right now.
Drug (ANDA Filed) Primary Patent Status Market Size
Eliquis 25 Expiring Soon $13.3B
Bridion 14 Expired $1.8B
Latuda 14 Expired -
Opsumit 11 Expired $2.3B
Tradjenta 11 Expired -

Drug patents lapsed
Spot drugs with expired patents that present new generic development opportunities.
Drug Patent Patent expiry
Amondys 45 8524880 02 Apr, 2026
Auvi-q 8926594 31 Mar, 2026
Auvi-q 8926594 31 Mar, 2026
Auvi-q 8926594 31 Mar, 2026
Bydureon 6515117*PED 04 Apr, 2026
Bydureon Bcise 6515117*PED 04 Apr, 2026
Bydureon Pen 6515117*PED 04 Apr, 2026
See more

Newly introduced Drug Patents
Discover the latest drugs receiving patent protection, signaling innovation and new market entrants
Drug Patent Patent expiry
Attruby 12539290 16 Aug, 2039
Blujepa 12528809 13 Dec, 2042
Brekiya (autoinjector) 12533351 26 Feb, 2039
Bylvay 12545705 08 Nov, 2031
Cyklx 11096922 27 Mar, 2039
Cyklx 11826347 27 Mar, 2039
Cyklx 12403126 27 Mar, 2039
See more

Recent patent litigations
Stay updated on recent drug patent lawsuits shaping the competitive landscape.
Patent Petitioner Proceeding Date
US12280146 Sun Pharmaceutical Industries, Inc. 16 Jan, 2026
US12233106 Ascendis Pharma A/s 24 Nov, 2025
US11344552 Apotex Inc. 12 Sep, 2025
US9474780 Bpi Labs, Llc 04 Aug, 2025
US8268847 United Therapeutics Corporation 10 Jun, 2025
US9474780 Empower Clinic Services, Llc. (D/b/a Empower Pharmacy) 22 May, 2025
US8623826 Azurity Pharmaceuticals, Inc. 01 May, 2025
See in detail
spacer_11
Companies with Newly Granted Drug Substance Patents
Company Ingredient
Biocryst Berotralstat Dihydrochloride
Eli Lilly And Co Tirzepatide
Glaxosmithkline Gepotidacin Mesylate
Rigel Pharms Pralsetinib
Takeda Pharms Usa Maribavir
spacer_11
View past newsletters
January, 2026
December, 2025
November, 2025

Our insights are consumed by 1000+ leading pharma companies

© 2026 GreyB Research